Filing Details
- Accession Number:
- 0001093557-20-000247
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2020-09-11 18:57:32
- Reporting Period:
- 2020-09-09
- Accepted Time:
- 2020-09-11 18:57:32
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1093557 | Dexcom Inc | DXCM | Surgical & Medical Instruments & Apparatus (3841) | 330857544 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1534342 | Donald Abbey | 6340 Sequence Drive San Diego CA 92121 | Evp Quality And Regulatory Aff | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Disposition | 2020-09-09 | 5,159 | $391.00 | 54,782 | No | 4 | S | Direct | |
Common Stock | Disposition | 2020-09-09 | 1,283 | $398.30 | 53,499 | No | 4 | S | Direct | |
Common Stock | Disposition | 2020-09-09 | 3,297 | $398.30 | 50,202 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct |
Footnotes
- The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 23, 2019, and amended effective May 11, 2020. This 10b5-1 Plan allows the orderly disposition of shares owned by Mr. Abbey.
- Included in this number are 22,722 restricted stock units, 8,811 of which were granted on March 8, 2020 and shall vest through March 8, 2023, 7,494 of which were granted on March 8, 2019 and shall vest through March 8, 2022, and 6,417 of which were granted on March 8, 2018 and shall vest through March 8, 2021.
- Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of RSUs. This sale is mandated by the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the reporting person.